China Pediatric Pharmaceuticals, Inc., which completed its reverse merger in October 2009, said its revenues rose 14% in 2009 to $16.7 million, though net income declined slightly to $2.5 million. The company ended its fiscal year with $900,000 in cash. Its only operating entity is Shaanxi Jiali Pharmaceutical Co., Ltd., headquartered in Xi’an. More details...

Stock Symbol: (OTCBB: CPDU)